Department of Hematology

Hematology Home >

Faculty

Peter J. O'Dwyer, M.D.

Professor of Medicine at the Hospital of the University of Pennsylvania and the Presbyterian Medical Center of Philadelphia

Department: Medicine

Contact information

16 Penn Tower
3400 Spruce Street
Philadelphia, PA 19104

Office: 215-662-7606
Fax: 215-349-8551

Email:
podwyer@mail.med.upenn.edu

Education:
M.D.
University of Dublin, Trinity College Dublin, Ireland, 1975.

Post-Graduate Training
Rotating Internship, Internal Medicine and Surgery , Sir Patrick Dun's Hospital, Dublin, Ireland, 1975-1976.
Senior House Officer, Department of Renal Medicine and Hematology, Hammersmith Hospital, London, England, 1976-1977.
Senior House Officer, Department of Rheumatology, Hammersmith Hospital, London, England, 1977-.
Resident, Pediatrics, Waterbury Hospital, Waterbury, Connecticut, 1977-1979.
Resident, Internal Medicine, Greater Baltimore Medical Center, Baltimore, Maryland, 1979-1981.
Fellow, Oncology, Baltimore Cancer Research Cancer, University of Maryland Hospital, Baltimore, Maryland, 1981-1982.

Certifications
American Boards of Pediatrics, .
Fellow, American College of Physicians, .
American Boards of Internal Medicine, .
Subspecialty Boards in Medical Oncology, .

Permanent link

> School of Medicine > Faculty > Details

Selected Publications

Yao KS, O’Dwyer PJ: Role of the AP-1 element in mediating transcriptional induction of DT-diaphorase gene expression by oltipraz: a target for chemoprevention. Biochem Pharmacol 2003 Notes: In Press.

Giantonio BJ, Derry C, McAleer C, McPhillips JJ, O’Dwyer PJ: Phase I and pharmacokinetic study of the cytotoxic ether lipid ilmofosine administered by weekly 2-hour infusion in patients with advanced solid tumors. 2003 Notes: In Press.

Flaherty KT, Stevenson JP, Hahn SM, Redlinger M, O’Dwyer PJ: Dose escalation and safety study of gemcitabine, carboplatin, and paclitaxel in patients with adavanced malignancy. Cancer Chemother Pharmacol 2003 Notes: In Press.

Flaherty KT, Stevenson JP, Gallagher M, Giantonio BJ, Algazy KM, Sun W, Haller DG, O’Dwyer PJ: Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer. Cancer 97: 1985-1990, 2003.

Johnston PG, Benson AB III, Catalano P, Rao MS, O’Dwyer PJ, Allegra C: Thymidylate synthase expression in primary colorectal cancer: lack of correlation with outcome and response to 5-FU in metastatic disease sites. J Clin Oncol 21: 815-819, 2003.

Extermann M, Bonetti M, Sledge G, O’Dwyer PJ, Bonomi P, Benson AB: MAX2: A convenient index to estimate the average per patient risk of severe toxicity from a chemotherapy regimen. Validation in ECOG trials. 2003 Notes: Manuscript submitted.

Vasilevskaya IA, Rakitina TV, O’Dwyer PJ: Geldanamycin and its 17-allylamino-17-demethoxy analogue (17-AAG) antagonize the action of cisplatin in human colon adenocarcinoma cells. Cancer Res 63: 3241-3246, 2003.

Itakura H, Vaughn D, Haller DG, O’Dwyer PJ: Rhabdomyolysis from cytochrome p450 interaction of ketoconazole and simvastatin in a patient with prostate cancer. J Urol 169: 613, 2003.

Shirao K, Hoff PM, Ohtsu A, Loehrer PJ, Hyodo I, Wadler S, Wadleigh RG, O’Dwyer PJ, Muro K, Yamada Y, Boku N, Nagashima F, Abbruzzese JL: Comparison between the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur plus oral leucovorin regimen in Japanese and American patients with advanced colorectal cancer: joint USA and Japan study of UFT/LV. 2003 Notes: Manuscript submitted.

Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu I-P, Hernandez-Boussard T, Johnson SW, O’Dwyer PJ, Fero M, Kristensen GB, Borresen-Dale A-L, Hastie T, Tibshirani R, van de Rijn M, Teng NN, Longacre TA, Botstein D, Brown PO, Sikic BI: Gene expression patterns in epithelial ovarian carcinomas. 2003 Notes: Manuscript submitted.